Intuitive Surgical Inc

Research Intuitive Surgical Inc (ISRG) on Bullrun: valuation model: 13.8% overvalued, market cap USD 151.34B, P/E 49.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Intuitive Surgical Inc as 13.8% overvalued; latest market cap is USD 151.34B; P/E is 49.0.

Peer valuation comparison

Latest P/E is 49.01x versus a Healthcare sector median of 24.6x (99.2% above).

Latest P/E is 49.01x versus a United States median of 23.85x (105.5% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 10.06BUSD 2.86BUSD 2.49B66.0%7.87USD 3.37Bn/aUSD 17.82B
FY2024USD 8.35BUSD 2.32BUSD 1.30B67.5%6.42USD 2.03Bn/aUSD 16.43B
FY2023USD 7.12BUSD 1.80BUSD 749.60M66.4%5.03USD 2.75Bn/aUSD 13.31B
FY2022USD 6.22BUSD 1.32BUSD 958.40M67.4%3.65USD 1.58Bn/aUSD 11.04B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-12USD 151.34B49.0n/an/a
20252025-12-31USD 201.11B71.9n/an/a
20242024-12-31USD 186.13B81.4n/an/a
20232023-12-29USD 118.77B79.4n/an/a
20222022-12-30USD 93.77B70.2n/an/a
20212021-12-31USD 128.52B77.1n/an/a

About Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.

ETFs that hold Intuitive Surgical Inc

Intuitive Surgical Inc is one of the ten largest holdings of 14 ETFs that investors in Europe can buy. The 8 most traded of them:

ETFWeightTER
iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)2.46%0.15%
L&G ROBO Global Robotics and Automation UCITS ETF1.93%0.80%
State Street SPDR S&P U.S. Health Care Select Sector UCITS ETF2.45%0.15%
Xtrackers MSCI USA Health Care UCITS ETF 1D3.29%0.12%
Mirae Asset Global X Robotics and Artificial Intelligence UCITS ETF6.59%0.50%
iShares AI Adopters & Applications UCITS ETF USD (Acc)1.88%0.35%
iShares US Medical Devices UCITS ETF USD (Acc)14.90%0.25%
Harbor Health Care UCITS ETF - Accumulating3.14%0.89%

Related stock research

United States stocks United States Healthcare stocks A-Z stock index

Other Healthcare stocks

Align Technology Inc (ALGN) Angiodynamic Inc (ANGO) Aptargroup Inc (ATR) Atricure Inc (ATRC) Avantor Inc (AVTR) Azenta Inc (AZTA) Baxter International Inc (BAX) Becton Dickinson & Company (BDX) Biolife Solutions Inc (BLFS) Bionano Genomics Inc (BNGO) Cooper Companies Inc (COO) Daxor Corp (DXR)

Frequently asked questions

Is Intuitive Surgical Inc overvalued or undervalued?

Bullrun's valuation model currently marks Intuitive Surgical Inc as 13.8% overvalued.

What is Intuitive Surgical Inc's market cap?

Intuitive Surgical Inc's market capitalization is USD 151.34B.

What is Intuitive Surgical Inc's P/E ratio?

Intuitive Surgical Inc's price-to-earnings (P/E) ratio is 49.0.

What does Intuitive Surgical Inc do?

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.